Impact of Peer Support on Diabetes in China

Not Applicable

• Conditions: Glucose Metabolism Disorders; Metabolic Diseases; Endocrine System Diseases; Diabetes

• Registration Number: NCT02119572
• Lead Sponsor: Zhongda Hospital

Brief Summary

The prevalence of diabetes has been growing rapidly in developing countries causing a devastating economic burden and increasing demands on healthcare systems. Therefore, there is an urgent need to find cost-effective and multi-faceted approach for diabetes care. Peer support models provide a potentially low-cost, flexible means that is complimentary to the current existing health care services. Trained peer leaders can become qualified extenders to a formal healthcare system, thereby, assisting with the education delivery and bolstering the efforts of the professional staff. To implement a culturally- specific peer support program and determine whether it is acceptable, cost-effective in China is important. This study aims to implement and evaluate biophysical and psychosocial outcomes of a peer support program and to explore it's feasibility and sustainability in China

Detailed Description

Not available

Study Timeline

• Status Verified: 2014-04
• Study First Submitted: 2014-04-15
• Study First Submitted QC: 2014-04-18
• Last Update Submitted: 2014-04-18
• Study First Posted: 2014-04-21
• Last Update Posted: 2014-04-21
• Primary Completion: 2016-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. type 2 diabetes
2. with voluntary participation and have signed the Patient Informed Consent Sheet
3. reside in stable places during the intervention period

Exclusion Criteria

1. Patients with reduced life expectancy and unstable mood or major psychiatric conditions
2. suffering from cancer and have been receiving radiotherapy and/ or chemotherapy in the past half year
3. enrolling in other research program at present

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change from Baseline HbA1c at 6 months,12 months	baselline,6months,12months

Secondary Outcome Measures

Name	Time	Method
Change from Baseline blood pressure at 6 months,12 months	baseline,6 months,12months
Change from Baseline months BMI at 6 months,12 months	baseline,6 months,12months
Change from Baseline months blood liquids at 6 months,12 months	baseline,6 months,12months
Change from Baseline months blood glucose at 6 months,12 months	baseline,6 months,12months
Change from baseline in diabetes self-care activities scales at 6 months,12months	baseline,6 months,12months
Change from baseline in depression scales at 6 months,12months	baseline,6 months,12months
Change from baseline in medication adherence scales at 6 months,12months	baseline,6 months,12months
Change from baseline in quality of life scales at 6 months,12months	baseline,6 months,12months
Change from baseline in diabetes self-efficacy scales at 6 months,12months	baseline,6 months,12months
Change from baseline in diabetes knowledge scales at 6 months,12months	baseline,6 months, 12 months
Change from baseline in positive and negative affectivity at 6 months,12months	baseline, 6 months,12months
Change from baseline in events of hypoglycemia at 6 months,12months	baseline,6 months,12months
Change from baseline advanced glycation end products at 6 months,12months	baseline ,6 months,12months
cost	baseline,6 months,12 months

Trial Locations

Locations (1)

Liuhe; 🇨🇳 Nanjing, Jiangsu, China